Skip to Main Content

School of Public Health: Chemtob Daniel

Researchers / חוקרים

 Last updated September 2023 - School of Public Health

List of Publications


Rouvinski A, Friedman A, Kirillov S, Attal JH, Kumari S, Fahoum J, et al. Antibody response in elderly vaccinated four times with an mRNA anti-COVID-19 vaccine. Scientific Reports [Internet]. 2023;13(1). Available from:


Günther G, Guglielmetti L, Leu C, van Leth F, Lange C, Hafizi H, et al. Relative cost of multidrug-resistant TB medicines in Europe. International Journal of Tuberculosis and Lung Disease [Internet]. 2023;27(5):341–4. Available from:


Wiessing L, Sypsa V, Abagiu AO, Arble A, Berndt N, Bosch A, et al. Impact of COVID-19 & Response Measures on HIV-HCV Prevention Services and Social Determinants in People Who Inject Drugs in 13 Sites with Recent HIV Outbreaks in Europe, North America and Israel. AIDS and Behavior [Internet]. 2023;27(4):1140–53. Available from:


Günther G, Guglielmetti L, Leu C, Lange C, van Leth F, Hafizi H, et al. Availability and costs of medicines for the treatment of tuberculosis in Europe. Clinical Microbiology and Infection [Internet]. 2023;29(1):77–84. Available from:


Guglielmetti L, Günther G, Leu C, Cirillo D, Duarte R, Garcia-Basteiro AL, et al. Rifapentine access in Europe: growing concerns over key tuberculosis treatment component. European Respiratory Journal [Internet]. 2022;59(5). Available from:


Wagner T, Zuckerman NS, Halperin T, Chemtob D, Levy I, Elbirt D, et al. Epidemiology and Transmitted HIV-1 Drug Resistance among Treatment-Naïve Individuals in Israel, 2010–2018. Viruses [Internet]. 2022;14(1). Available from:


Chemtob D, Levy I, Kaufman S, Averick N, Krauss A, Turner D. Drop-out of medical follow-up among people living with HIV in Tel-Aviv area. AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV [Internet]. 2022;34(5):621–5. Available from:


Chemtob D, Weil C, Attal JH, Hawila E, Sadeh EN. HIV Pre-Exposure Prophylaxis (PrEP) purchase patterns and STI occurrence among Israeli men: A cohort analysis. PLoS ONE [Internet]. 2021;16(11 November). Available from:


Chemtob D, Ogum E. Tuberculosis treatment outcomes of non-citizen migrants: Israel compared to other high-income countries. Israel Journal of Health Policy Research [Internet]. 2020;9(1). Available from:


Des Jarlais DC, Sypsa V, Feelemyer J, Abagiu AO, Arendt V, Broz D, et al. HIV outbreaks among people who inject drugs in Europe, North America, and Israel. The Lancet HIV [Internet]. 2020;7(6):e434–42. Available from:


Chowers M, Chemtob D, Mor O, Levy I, Elbirt D, Elinav H, et al. Continuum of HIV care of newly diagnosed individuals in Israel, 2011–2015: a population-based cohort study. International Journal of STD and AIDS [Internet]. 2020;31(4):326–34. Available from:


Ginsberg GM, Chemtob D. Cost utility analysis of HIV pre exposure prophylaxis among men who have sex with men in Israel. BMC Public Health [Internet]. 2020;20(1). Available from:


Bishara H, Green M, Chemtob D, Saffouri A, Zelikman L, Weiler-Ravell D. Ongoing tuberculosis transmission among second-generation Ethiopian immigrants in Israel. Epidemiology and Infection [Internet]. 2020; Available from:


Mårdh O, Quinten C, Kuchukhidze G, Seguy N, Dara M, Amato-Gauci AJ, et al. HIV among women in the WHO European Region – Epidemiological trends and predictors of late diagnosis, 2009-2018. Eurosurveillance [Internet]. 2019;24(48). Available from:


Hayes R, Schmidt AJ, Pharris A, Azad Y, Brown AE, Weatherburn P, et al. Estimating the “PrEP Gap”: How implementation and access to PrEP differ between countries in Europe and Central Asia in 2019. Eurosurveillance [Internet]. 2019;24(41). Available from:


Chemtob D, Mor Z, Harel N, Averick N. HIV infection among men who have sex with men in Israel: A 35-year epidemiological and clinical overview, 1981-2015. BMC Public Health [Internet]. 2019;19(1). Available from:


Ganzel C, Silverman B, Chemtob D, Ben Shoham A, Wiener-Well Y. The risk of tuberculosis in cancer patients is greatest in lymphoma and myelodysplastic syndrome/myeloproliferative neoplasm: a large population-based cohort study. Leukemia and Lymphoma [Internet]. 2019;60(3):720–5. Available from:


Kiros YK, Elinav H, Gebreyesus A, Gebremeskel H, Azar J, Chemtob D, et al. Identification and characterization of HIV positive Ethiopian elite controllers in both Africa and Israel. HIV Medicine [Internet]. 2019;20(1):33–7. Available from:


Brown AE, Hayes R, Noori T, Azad Y, Amato-Gauci AJ, Pharris A, et al. HIV in Europe and central Asia: Progress in 2018 towards meeting the UNAIDS 90-90-90 targets. Eurosurveillance [Internet]. 2018;23(48). Available from:


Bui LV, Mor Z, Chemtob D, Ha ST, Levine H. Use of geographically weighted poisson regression to examine the effect of distance on tuberculosis incidence: A case study in Nam Dinh, Vietnam. PLoS ONE [Internet]. 2018;13(11). Available from:


Avidor B, Chemtob D, Turner D, Zeldis I, Girshengorn S, Matus N, et al. Evaluation of the virtues and pitfalls in an HIV screening algorithm based on two fourth generation assays – A step towards an improved national algorithm. Journal of Clinical Virology [Internet]. 2018;106:18–22. Available from:


Popovici O, Monk P, Chemtob D, Chiotan D, Freidlin PJ, Groenheit R, et al. Cross-border outbreak of extensively drug-resistant tuberculosis linked to a university in Romania. Epidemiology and Infection [Internet]. 2018;146(7):824–31. Available from:


Rakovsky A, Gozlan Y, Bassal R, Wax M, Shirazi R, Bakhanashvili M, et al. Diagnosis of HIV-1 infection: Performance of Xpert Qual and Geenius supplemental assays in fourth generation ELISA-reactive samples. Journal of Clinical Virology [Internet]. 2018;101:7–10. Available from:


Mor Z, Sheffer R, Chemtob D. Causes of death and mortality trends of all individuals reported with HIV/AIDS in Israel, 1985-2010. Journal of Public Health (United Kingdom) [Internet]. 2018;40(1):56–64. Available from:


Mor Z, Sheffer R, Chemtob D. Mother-to-child HIV transmissions in Israel, 1985-2011. Epidemiology and Infection [Internet]. 2017;145(9):1913–21. Available from:


Katchman E, Ben-Ami R, Savyon M, Chemtob D, Avidor B, Wasserman A, et al. Successful control of a large outbreak of HIV infection associated with injection of cathinone derivatives in Tel Aviv, Israel. Clinical Microbiology and Infection [Internet]. 2017;23(5):336.e5-336.e8. Available from:


Chemtob D, Gandacu D, Mor Z, Grotto I, Anis E, Rosenberg E. A national strategic plan for reducing the burden of sexually transmitted infections in Israel by the year 2025. Israel Journal of Health Policy Research [Internet]. 2017;6(1). Available from:


Freidlin PJ, Nissan I, Luria A, Goldblatt D, Schaffer L, Kaidar-Shwartz H, et al. Structure and variation of CRISPR and CRISPR-flanking regions in deleted-direct repeat region Mycobacterium tuberculosis complex strains. BMC Genomics [Internet]. 2017;18(1). Available from:


Chowers M, Regev-Yochay G, Mor O, Cohen-Poradosu R, Riesenberg K, Zimhony O, et al. Invasive pneumococcal disease (IPD) in HIV infected patients in Israel since the introduction of pneumococcal conjugated vaccines (PCV): Analysis of a nationwide surveillance study, 2009–2014. Human Vaccines and Immunotherapeutics [Internet]. 2017;13(1):216–9. Available from:


Ginsberg GM, Shinar E, Kopel E, Chemtob D. Should Men who have sex with Men be allowed to donate blood in Israel. Israel Journal of Health Policy Research [Internet]. 2016;5(1). Available from:


Mor Z, Lidji M, Chemtob D, Cedar N, Grotto I. Erratum: “HIV prevalence in the Israeli tuberculosis cohort, 1999-2011” (BMC Public Health (2014) 14 (1090)). BMC Public Health [Internet]. 2016;16(1). Available from:


Hofstra LM, Sauvageot N, Albert J, Alexiev I, Garcia F, Struck D, et al. Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe. Clinical Infectious Diseases [Internet]. 2016;62(5):655–63. Available from:


Shuldiner J, Leventhal A, Chemtob D, Mor Z. Mortality after anti-tuberculosis treatment completion: Results of long-term follow-up. International Journal of Tuberculosis and Lung Disease [Internet]. 2016;20(1):43–8. Available from:


Chemtob D, Op de Coul E, van Sighem A, Mor Z, Cazein F, Semaille C. Impact of Male Circumcision among heterosexual HIV cases: Comparisons between three low HIV prevalence countries. Israel Journal of Health Policy Research [Internet]. 2015;4(1). Available from:


Chemtob D, Mor Z, Grotto I. Tuberculosis screening programmes for migrants to low-incidence countries-the Israeli experience. The Lancet Infectious Diseases [Internet]. 2015;15(8):876. Available from:


Lönnroth K, Migliori GB, Abubakar I, D’Ambrosio L, De Vries G, Diel R, et al. Towards tuberculosis elimination: An action framework for low-incidence countries. European Respiratory Journal [Internet]. 2015;45(4):928–52. Available from:


Mor Z, Goldblatt D, Kaidar-Shwartz H, Cedar N, Rorman E, Chemtob D. Drug-resistant tuberculosis in Israel: Risk factors and treatment outcomes. International Journal of Tuberculosis and Lung Disease [Internet]. 2014;18(10):1195–201. Available from:


Goldblatt D, Rorman E, Chemtob D, Freidlin PJ, Cedar N, Kaidar-Shwartz H, et al. Molecular epidemiology and mapping of tuberculosis in Israel: Do migrants transmit the disease to locals? International Journal of Tuberculosis and Lung Disease [Internet]. 2014;18(9):1085–91. Available from:


Frentz D, Van de Vijver DAMC, Abecasis AB, Albert J, Hamouda O, Jørgensen LB, et al. Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe. BMC Infectious Diseases [Internet]. 2014;14(1). Available from:


Shuldiner J, Leventhal A, Chemtob D, Mor Z. Mortality of tuberculosis patients during treatment in israel, 2000-2010. International Journal of Tuberculosis and Lung Disease [Internet]. 2014;18(7):818-823+ii. Available from:


D’Ambrosio L, Dara M, Tadolini M, Centis R, Sotgiu G, Van Der Werf MJ, et al. Tuberculosis elimination: Theory and practice in Europe. European Respiratory Journal [Internet]. 2014;43(5):1410–20. Available from:


Mor Z, Weinstein R, Grotto I, Levin Y, Chemtob D. Thirty years of HIV in Israel: Current epidemiology and future challenges. BMJ Open [Internet]. 2013;3(7). Available from:


Frentz D, Wensing AMJ, Albert J, Paraskevis D, Abecasis AB, Hamouda O, et al. Limited cross-border infections in patients newly diagnosed with HIV in Europe. Retrovirology [Internet]. 2013;10(1). Available from:


Theys K, Deforche K, Vercauteren J, Libin P, van de Vijver DAMC, Albert J, et al. Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients. Retrovirology [Internet]. 2012;9. Available from:


Chemtob D, Zenilman JM, Gandacu D. What do we need to learn for policy decision-making on sexually transmitted infections prevention and treatment in Israel? International Journal of STD and AIDS [Internet]. 2012;23(9):e11–5. Available from:


Merrick J, Talnir R, Gross S, Chemtob D, Aspler S, Kandel I, et al. Human immunodeficiency virus (HIV) and persons with disability/intellectual disability [Internet]. AIDS and Tuberculosis: Public Health Aspects. 2012. Available from:


Schenker I, Chemtob D, Yamin N, Shtechman N, Rosenberg H. The National HIV/AIDS hotline in Israel: Data on utilization, quality assurance and content [Internet]. AIDS and Tuberculosis: Public Health Aspects. 2012. Available from:


Chemtob D, Gurevitz M, Levitt S, Basudo-Manor N, Shufman E, Maayan S. Epidemiology of Hepatitis B, Hepatitis C and HIV infections among intravenous drug users in Jerusalem, Israel [Internet]. AIDS and Tuberculosis: Public Health Aspects. 2012. Available from:


Chemtob D, Merrick J. Introduction: Preventing and treating tuberculosis and HIV/AIDS. A worldwide public health challenge [Internet]. AIDS and Tuberculosis: Public Health Aspects. 2012. Available from:


Chemtob D, Merrick J. AIDS and Tuberculosis: Public Health Aspects [Internet]. AIDS and Tuberculosis: Public Health Aspects. 2012. Available from:


Chemtob D, Rosenberg E. Healthy Israel 2020: Objectives, targets, and evidence-based strategies to prevent tuberculosis and HIV infection in Israel [Internet]. AIDS and Tuberculosis: Public Health Aspects. 2012. Available from:


Gross S, Merrick J, Talnir R, Aspler S, Kandel I, Morad M, et al. Human immunodificiency virus (HIV) in a residential care center for persons with intellectual disability in Israel: A needle in a haystack investigation [Internet]. AIDS and Tuberculosis: Public Health Aspects. 2012. Available from:


Mor Z, Davidovich U, Bessudu-Manor N, McFarlane M, Feldshtein G, Chemtob D. High-risk behaviour in steady and in casual relationships among men who have sex with men in Israel. Sexually Transmitted Infections [Internet]. 2011;87(6):532–7. Available from:


Alvarez GG, Clark M, Altpeter E, Douglas P, Jones J, Paty MC, et al. Pediatric tuberculosis immigration screening in high-immigration, low-incidence countries (International Journal of Tuberculosis and Lung Disease (2010) 14, 12, (1530-1537)). International Journal of Tuberculosis and Lung Disease [Internet]. 2011;15(3):425. Available from:


Alvarez GG, Gushulak B, Rumman KA, Altpeter E, Chemtob D, Douglas P, et al. A comparative examination of tuberculosis immigration medical screening programs from selected countries with high immigration and low tuberculosis incidence rates. BMC Infectious Diseases [Internet]. 2011;11. Available from:


Alvarez GG, Clark M, Altpeter E, Douglas P, Jones J, Paty MC, et al. Pediatric tuberculosis immigration screening in high-immigration, low-incidence countries. International Journal of Tuberculosis and Lung Disease [Internet]. 2010;14(12):1530–7. Available from:


Erkens CGM, Kamphorst M, Abubakar I, Bothamley GH, Chemtob D, Haas W, et al. Tuberculosis contact investigation in low prevalence countries: A European consensus. European Respiratory Journal [Internet]. 2010;36(4):925–49. Available from:


Chemtob D, Levy A. Rationale and staff evaluation of using a therapeutic milieu for substance users within a tuberculosis ward. Substance Use and Misuse [Internet]. 2009;44(5):672–83. Available from:


Attamna A, Chemtob D, Attamna S, Fraser A, Rorman E, Paul M, et al. Risk of tuberculosis in close contacts of patients with multidrug resistant tuberculosis: A nationwide cohort. Thorax [Internet]. 2009;64(3):271. Available from:


Bothamley GH, Ditiu L, Migliori GB, Lange C, Hafizi H, Mezhlumyan N, et al. Active case finding of tuberculosis in Europe: A Tuberculosis Network European Trials Group (TBNET) survey. European Respiratory Journal [Internet]. 2008;32(4):1023–30. Available from:


Mor Z, Davidovich U, McFarlane M, Feldshtein G, Chemtob D. Gay men who engage in substance use and sexual risk behaviour: A dual-risk group with unique characteristics. International Journal of STD and AIDS [Internet]. 2008;19(10):698–703. Available from:


Chemtob D, Levit S, Mell H, Margolis A, Levy A, Leventhal A. “Injecting clean or being clean?” The International and Israeli experiences of Syringe Exchange Programs among injecting drugs users. Harefuah [Internet]. 2008;147(7):634–8. Available from:


Chemtob D. Mortality of hospitalized tuberculosis patients in Israel. The Israel Medical Association journal : IMAJ [Internet]. 2008;10(3). Available from:


Mor Z, Adler A, Leventhal A, Volovic I, Rosenfeld E, Lobato MN, et al. Tuberculosis behind bars in Israel: Policy making within a dynamic situation. Israel Medical Association Journal [Internet]. 2008;10(3):202–6. Available from:


Mor Z, Chemtob D, Hildesheimer GM, Leventhal A. Aids and the right to privacy. Harefuah [Internet]. 2007;146(3):200–5. Available from:


Chemtob D, Sasson M, Leventhal A, Stein-Zamir C, Maayan S. Sexually transmitted infections among individuals with and without HIV [1]. Israel Medical Association Journal [Internet]. 2006;8(12):892. Available from:


Mor Z, Chemtob D, Pessach N, Nitzan-Kaluski D. Human immunodeficiency virus in newborn of infected mothers: Pregnancy, breast feeding and prevention. Harefuah [Internet]. 2006;145(9):682–6. Available from:


Chemtob D, Damelin B, Bessudo-Manor N, Hassman R, Amikam Y, Zenilman JM, et al. “Getting AIDS: Not in my back yard.” Results from a national knowledge, attitudes and practices survey. Israel Medical Association Journal [Internet]. 2006;8(9):610–4. Available from:


Chemtob D, Weiler-Ravell D, Leventhal A, Bibi H. Epidemiologic characteristics of pediatric active tuberculosis among immigrants from high to low tuberculosis-endemic countries: The Israeli experience. Israel Medical Association Journal [Internet]. 2006;8(1):21–6. Available from:


Chemtob D, Srour SF. Epidemiology of HIV infection among Israeli Arabs. Public Health [Internet]. 2005;119(2):138–43. Available from:


Chemtob D, Grossman Z. Epidemiology of adult and adolescent HIV infection in Israel: A country of immigration. International Journal of STD and AIDS [Internet]. 2004;15(10):691–6. Available from:


Weiler-Ravell D, Leventhal A, Berlowitz Y, Rishpon S, Chemtob D. Circumstances leading to the formulation and implementation of a new TB control program in Israel: A case study in public health and policy. Journal of Public Health Policy [Internet]. 2004;25(1):23–37. Available from:


Weiler-Ravell D, Leventhal A, Coker RJ, Chemtob D. Compulsory detention of recalcitrant tuberculosis patients in the context of a new uberculosis control programme in Israel. Public Health [Internet]. 2004;118(5):323–8. Available from:


Chemtob D, Leventhal A, Weiler-Ravell D. Screening and management of tuberculosis in immigrants: The challenge beyond professional competence. International Journal of Tuberculosis and Lung Disease [Internet]. 2003;7(10):959–66. Available from:


Chemtob D, Leventhal A, Berlowitz Y, Weiler-Ravell D. The new National Tuberculosis Control Programme in Israel, a country of high immigration. International Journal of Tuberculosis and Lung Disease [Internet]. 2003;7(9):828–36. Available from:


Leventhal A, Berlowitz Y, Chemtob D. Migrant workers: Evolution of the Israel health system approach to the new social issue. Harefuah [Internet]. 2003;142(8–9):632-635+644. Available from:


Chemtob D, Nitzan Kaluski D. Political commitment and public health prioritization. Israel Medical Association Journal [Internet]. 2002;4(3):234. Available from:


Bibi H, Weiler-Ravell D, Shoseyov D, Feigin I, Arbelli Y, Chemtob D. Compliance to treatment of latent tuberculosis infection in a region of Israel. Israel Medical Association Journal [Internet]. 2002;4(1):13–6. Available from:


Chemtob D, Leventhal A, Weiler-Ravell D. Tuberculosis in Israel–main epidemiological aspects. Harefuah [Internet]. 2002;141(3):226–32, 316. Available from:


Chemtob D, Leventhal A, Berlowitz Y, Weiler-Ravell D. The new national program for tuberculosis elimination in Israel. Harefuah [Internet]. 2002;141(3):265–71, 314. Available from:


Grossman Z, Vardinon N, Chemtob D, Alkan ML, Bentwich Z, Burke M, et al. Erratum: Genotypic variation of HIV-1 reverse transcriptase and protease: Comparative analysis of clade C and clade B (AIDS (2001) 15 (1453-1460)). [1]. AIDS [Internet]. 2001;15(16):2209. Available from:


Chemtob D, Epstein L, Slater PE, Weiler-Ravell D. Epidemiological analysis of tuberculosis treatment outcome as a tool for changing TB control policy in Israel. Israel Medical Association Journal [Internet]. 2001;3(7):479–83. Available from:


Grossman Z, Vardinon N, Chemtob D, Alkan ML, Bentwich Z, Burke M, et al. Genotypic variation of HIV-1 reverse transcriptase and protease: Comparative analysis of clade C and clade B. AIDS [Internet]. 2001;15(12):1453–60. Available from:


Ravins M, Bercovier H, Chemtob D, Fishman Y, Rahav G. Molecular epidemiology of Mycobacterium tuberculosis infection in Israel. Journal of Clinical Microbiology [Internet]. 2001;39(3):1175–7. Available from:


Chemtob D, Weiler-Ravell D, Ben-Dov I. Incorrect estimation of TB drug resistance in Israel, probably due to recruitment and collection biases [2] (multiple letters). International Journal of Tuberculosis and Lung Disease [Internet]. 2000;4(10):990–2. Available from:


Srour-Fihmi S, Weiler-Ravell D, Kitzes R, Chemtob D. Routine two-step skin testing for tuberculosis in the staff of a geriatric hospital in Israel: Booster and conversion rates. Journal of Hospital Infection [Internet]. 2000;46(2):141–6. Available from:


Senba M, Chemtob D, Slater PE, Fassberg J, Larouze B. Prevention of chronic carriage of hepatitis B virus infection in Ethiopian immigrants [2]. Israel Journal of Medical Sciences [Internet]. 1992;28(5):308–9. Available from:


Chemtob D, Fassberg J, Kalka I, Harlap S, Slater PE, Ever-Hadani P, et al. Prevention strategy of hepatitis B virus infection among the Ethiopian Community in Israel. Israel Journal of Medical Sciences [Internet]. 1991;27(5):273–7. Available from:


Chemtob D, Kalka I, Fassberg Y. Research note: Blood drawing and hepatitis B ‐‐ the case of Ethiopian Jews in Israel. Sociology of Health & Illness [Internet]. 1990;12(2):216–26. Available from: